Advertisement
UK markets closed

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     

  • AIM

    789.87
    +6.17 (+0.79%)
     

  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    48,603.21
    -1,599.11 (-3.19%)
     

  • CMC Crypto 200

    1,261.40
    -96.61 (-7.11%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Company News For Jan 29, 2020

Zacks Equity Research
·1-min read

  • Shares of Armata Pharmaceuticals, Inc. ARMP surged 77.1% after the company along with Innoviva, reported a $25 million strategic investment to support the progress of Armata's bacteriophage development programs.

  • Shares of Ocean Bio-Chem, Inc. OBCI gained 18.8% after the company's subsidiary, Star Brite, announced its product PERFORMACIDE is registered with EPA as a virucide against the coronavirus.

  • Shares of Graco Inc. GGG rose 7.1% after the company reported quarterly earnings of 48 cents per share, which surpassed the Zacks Consensus Estimate of 39 cents.

  • Shares of 3M Company MMM declined 5.7% after the company’s quarterly earnings of $1.95 per share missed the Zacks Consensus Estimate of $2.10.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
3M Company (MMM) : Free Stock Analysis Report
 
Graco Inc. (GGG) : Free Stock Analysis Report
 
AmpliPhi Biosciences Corporation (ARMP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research